Vergoeding 2017-2021 voor ATC-subgroep J01 : Antibacteriele middelen voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| J01A Tetracyclines | 3.159.300 | 2.767.100 | 2.602.900 | 2.486.500 | 3.903.500 |
| J01B Amfenicolen | . | . | 10 | . | . |
| J01C Betalactam-antibiotica penicillines | 8.002.400 | 8.621.600 | 10.308.800 | 11.390.700 | 13.630.100 |
| J01D Overige betalactam-antibiotica | 4.417.100 | 4.706.300 | 5.367.000 | 5.532.300 | 5.965.700 |
| J01E Sulfonamiden en trimethoprim | 1.009.300 | 1.071.000 | 1.326.000 | 1.369.300 | 1.410.800 |
| J01F Macroliden lincosamiden en streptograminen | 3.970.600 | 4.015.100 | 4.758.700 | 4.242.800 | 3.163.900 |
| J01G Aminoglycosiden | 5.001.800 | 4.486.000 | 4.384.200 | 4.163.300 | 4.165.200 |
| J01M Chinolonen | 1.747.500 | 2.150.700 | 2.316.700 | 2.418.500 | 2.350.300 |
| J01X Overige antibacteriele middelen | 10.262.200 | 9.629.300 | 10.220.000 | 10.455.100 | 10.854.100 |
| Totaal | 37.570.200 | 37.447.100 | 41.284.310 | 42.058.500 | 45.443.600 |